Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 1
2005 3
2006 2
2009 2
2010 3
2011 4
2012 4
2014 3
2015 2
2017 2
2018 3
2019 4
2020 4
2021 2
2022 6
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
NEK11 as a candidate high-penetrance melanoma susceptibility gene.
Christodoulou E, van Doorn R, Visser M, Teunisse A, Versluis M, van der Velden P, Hayward NK, Jochemsen A, Gruis N. Christodoulou E, et al. Among authors: teunisse a. J Med Genet. 2020 Mar;57(3):203-210. doi: 10.1136/jmedgenet-2019-106134. Epub 2019 Nov 8. J Med Genet. 2020. PMID: 31704778
Breast cancer dormancy is associated with a 4NG1 state and not senescence.
Prunier C, Alay A, van Dijk M, Ammerlaan KL, van Gelderen S, Marvin DL, Teunisse A, Slieker RC, Szuhai K, Jochemsen AG, Solé X, Ten Dijke P, Ritsma L. Prunier C, et al. Among authors: teunisse a. NPJ Breast Cancer. 2021 Oct 27;7(1):140. doi: 10.1038/s41523-021-00347-0. NPJ Breast Cancer. 2021. PMID: 34707097 Free PMC article.
Chk2 mediates RITA-induced apoptosis.
de Lange J, Verlaan-de Vries M, Teunisse AF, Jochemsen AG. de Lange J, et al. Among authors: teunisse af. Cell Death Differ. 2012 Jun;19(6):980-9. doi: 10.1038/cdd.2011.182. Epub 2011 Dec 9. Cell Death Differ. 2012. PMID: 22158418 Free PMC article.
Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status.
Mejía-Hernández JO, Raghu D, Caramia F, Clemons N, Fujihara K, Riseborough T, Teunisse A, Jochemsen AG, Abrahmsén L, Blandino G, Russo A, Gamell C, Fox SB, Mitchell C, Takano EA, Byrne D, Miranda PJ, Saleh R, Thorne H, Sandhu S, Williams SG, Keam SP, Haupt Y, Haupt S. Mejía-Hernández JO, et al. Among authors: teunisse a. Cancers (Basel). 2022 Aug 16;14(16):3947. doi: 10.3390/cancers14163947. Cancers (Basel). 2022. PMID: 36010941 Free PMC article.
Analysis of CRISPR-Cas9 screens identifies genetic dependencies in melanoma.
Christodoulou E, Rashid M, Pacini C, Droop A, Robertson H, Groningen TV, Teunisse AFAS, Iorio F, Jochemsen AG, Adams DJ, Doorn RV. Christodoulou E, et al. Among authors: teunisse afas. Pigment Cell Melanoma Res. 2021 Jan;34(1):122-131. doi: 10.1111/pcmr.12919. Epub 2020 Sep 7. Pigment Cell Melanoma Res. 2021. PMID: 32767816 Free PMC article.
MDM4 is a rational target for treating breast cancers with mutant p53.
Miranda PJ, Buckley D, Raghu D, Pang JB, Takano EA, Vijayakumaran R, Teunisse AF, Posner A, Procter T, Herold MJ, Gamell C, Marine JC, Fox SB, Jochemsen A, Haupt S, Haupt Y. Miranda PJ, et al. Among authors: teunisse af. J Pathol. 2017 Apr;241(5):661-670. doi: 10.1002/path.4877. Epub 2017 Mar 1. J Pathol. 2017. PMID: 28097652
40 results